Author: Dr. I. LeMarquis from the Bioplasty International Center
Medical techniques and expertise in the sculpting process bioplasty involves, cannot be decreased in importance since the impeccable and most neat performance of the procedure focuses on the deep PMMA inner micro spheres placement and outer volume and contouring of softer tissues at the same time.
The use of a legal and officially approved PMMA brand in Colombia is our guarantee of the legitimacy of a substance produced to stand apart from potential health risks associated to silicone injections and low quality chemically produced substances that do not meet standards.
Microspheres of Polymethylmethacrylate (PMMA) have been implanted in human body for long, yet only recent years brought us the final answer as far as aesthetic improvement is concerned. Artecoll developed in Germany in 1994 by professor Gottfriend has widely spread in Europe, South America and Canada; complications as such are very rare, negative rate is practically nonexistent, in orthopedic surgery satisfactory records are simply amazing.
The process for producing PMMA microspheres is extremely unique being that it aims to generate perfectly round microspheres which are totally free of contamination; this is very important since only exceptionally smooth surfaces will promote rapid encapsulation by collagen and patient’s own self defense mechanisms to isolate a foreign visitor. It is theorized microspheres that lack the process where they are brought into exact sizes, large enough to avoid migration and phagocytosis yet sufficiently small as to pass through infiltration cannulas, are bound to end up in failure.
Substances that have not engaged with excellence will often be found in underground brands which use materials that are produced under poor manufacturing standards commonly tempted by financial benefits, putting aside the relevance perfectly smooth PMMA microspheres’ surfaces have within the whole context involved in bioplasty.
Irregular spheres, smaller sizes than needed, sharp edges produced by non-selective enough and poor chemical processes, will derive into obvious lesser quality substances which surely will also lack approval and official health certification; however equally reaching people under different speeches and statements.
PMMA microspheres will remain deeply placed at inner gluteus anatomical planes forming a mesh-like inner interconnection of soft tissues growth, i.e. connective tissue formation cushioned and amalgamated through vector substance’s presence.
Vector substances on the other hand, are another subject to be cautious about since a variety of them ranging from silicone gel to biopolymers and plain H2O solution are common among underground brands.
Vehicles used in Artecoll and Juvederm suffer fast resorption, whilst on the other hand, collagen and hyaluronic compounds are not really adequate for large muscles groups’ enhancement and augmenting, where a much more dense substance is needed along with longer permanence in the body too.
Carboxymethylcellulose is a biocompatible vehicle that holds high durability and cohesiveness properties to the extent of being considered a superior quality permanent filler.
Several years of optimum results is the normal final turnout Bioplasty offers; carrier substance lasting a long time rather than one or two years, is crucial not only to comply with patient’s most evident expectations, but for the perfect integration of both PMMA microspheres and outer superficial levels where tissues retraction, resorption, aging, volume loss, sinking areas, low muscles development, are mostly evident.
Carboxymethylcellulose makes an outstanding vehicle since, not only volume and shape are kept intact for longer periods of time, but also carrier being highly cohesive itself, will add and maintain a perfect balance between PMMA implantation, amalgamating and cushioning inner and outer anatomical planes for an optimum integration of the whole context.
Fast resorbed substances’ manufacturers claim inner connective tissue encapsulation is sufficient to generate outer treated areas relevance too, stating once carrier vehicle biodegrades, procedure will have sufficient body in itself as to cover a role impossible to be met through PMMA microspheres implantation only; expecting volume and corrections mostly evidenced at superficial levels to be solved out by connective tissue formation is not quite feasible in our opinion.




